These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3533304)

  • 1. Enhancement of the clonability of adult parenchymal hepatocytes with the liver tumor promoter phenobarbital.
    Jirtle RL; Michalopoulos G
    Carcinogenesis; 1986 Nov; 7(11):1813-7. PubMed ID: 3533304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo response of hepatocytes from hepatic nodules to the mitoinhibitory effects of phenobarbital.
    Manjeshwar S; Laconi E; Sheikh A; Rao PM; Rajalakshmi S; Sarma DS
    Carcinogenesis; 1994 Sep; 15(9):1963-8. PubMed ID: 7923591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenobarbital-dependent proliferation of putative initiated rat hepatocytes.
    Kaufmann WK; Ririe DG; Kaufman DG
    Carcinogenesis; 1988 May; 9(5):779-82. PubMed ID: 3130204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital.
    Hanigan MH; Pitot HC
    Cancer Res; 1985 Dec; 45(12 Pt 1):6063-70. PubMed ID: 3904978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-alpha sustains clonal expansion by promoter-dependent, chemically initiated rat hepatocytes.
    Kaufmann WK; Byrd LL; Palmieri D; Nims RW; Rice JM
    Carcinogenesis; 1997 Jul; 18(7):1381-7. PubMed ID: 9230284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of partial hepatectomy on transplanted hepatocytes.
    Jirtle RL; Michalopoulos G
    Cancer Res; 1982 Aug; 42(8):3000-4. PubMed ID: 7046913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effect of enzymatically modified isoquercitrin on phenobarbital-induced liver tumor promotion in rats.
    Morita R; Shimamoto K; Ishii Y; Kuwata K; Ogawa B; Imaoka M; Hayashi SM; Suzuki K; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Nov; 85(11):1475-84. PubMed ID: 21445586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of DNA synthesis by phenobarbital in primary cultures of hepatocytes from normal rat liver and from hepatic nodules.
    Manjeshwar S; Rao PM; Rajalakshmi S; Sarma DS
    Carcinogenesis; 1992 Dec; 13(12):2287-91. PubMed ID: 1473236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation.
    Eckl PM; Meyer SA; Whitcombe WR; Jirtle RL
    Carcinogenesis; 1988 Mar; 9(3):479-83. PubMed ID: 3257910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of partial hepatectomy to induce gamma-glutamyltranspeptidase in regenerated and transplanted hepatocytes of Fischer 344 and Wistar-Furth rats.
    Bone SN; Michalopoulos G; Jirtle RL
    Cancer Res; 1985 Mar; 45(3):1222-8. PubMed ID: 2857593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for lack of promotion of the growth of the common naturally occurring basophilic focal hepatocellular proliferative lesions in aged F344/NCr rats by phenobarbital.
    Ward JM; Ohshima M
    Carcinogenesis; 1985 Sep; 6(9):1255-9. PubMed ID: 2863006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase enhances early hepatocyte inclusion in the recipient liver after transplantation in partially hepatectomized rats.
    Tsiperson V; Goldshmidt O; Ilan N; Shoshany G; Vlodavsky I; Veitsman E; Baruch Y
    Tissue Eng Part A; 2008 Mar; 14(3):449-58. PubMed ID: 18333797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver.
    Yamada T; Okuda Y; Kushida M; Sumida K; Takeuchi H; Nagahori H; Fukuda T; Lake BG; Cohen SM; Kawamura S
    Toxicol Sci; 2014 Nov; 142(1):137-57. PubMed ID: 25145657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible and phorbol ester-specific defect of protein kinase C translocation in hepatocytes isolated from phenobarbital-treated rats.
    Brockenbrough JS; Meyer SA; Li CX; Jirtle RL
    Cancer Res; 1991 Jan; 51(1):130-6. PubMed ID: 1988078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital.
    Jirtle RL; Hankins GR; Reisenbichler H; Boyer IJ
    Carcinogenesis; 1994 Aug; 15(8):1473-8. PubMed ID: 8055622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain and species effects on the inhibition of hepatocyte intercellular communication by liver tumor promoters.
    Klaunig JE; Ruch RJ
    Cancer Lett; 1987 Aug; 36(2):161-8. PubMed ID: 3621148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of hepatocytes isolated from phenobarbitone treated mice to mitogenic growth factors.
    Fletcher K; Orton TC; Chipman JK; Strain AJ
    Arch Toxicol; 1997; 71(7):422-8. PubMed ID: 9209687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver regeneration and alpha-fetoprotein messenger RNA expression in the retrorsine model for hepatocyte transplantation.
    Dabeva MD; Laconi E; Oren R; Petkov PM; Hurston E; Shafritz DA
    Cancer Res; 1998 Dec; 58(24):5825-34. PubMed ID: 9865742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenobarbital promotion in diethylnitrosamine-initiated infant B6C3F1 mice: influence of gender.
    Weghorst CM; Klaunig JE
    Carcinogenesis; 1989 Mar; 10(3):609-12. PubMed ID: 2924405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of liver tumor-initiating activity of kojic acid in mice.
    Moto M; Mori T; Okamura M; Kashida Y; Mitsumori K
    Arch Toxicol; 2006 May; 80(5):299-304. PubMed ID: 16231124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.